课题基金 / 基金详情

BIFUNCTIONAL CHELATING AGENTS IN TUMOR LOCALIZATION

BIFUNCTIONAL CHELATING AGENTS IN TUMOR LOCALIZATION
双功能螯合剂在肿瘤定位中的应用
批准号:
6308883
负责人:
CLAUDE F. MEARES
金额:
$0.99万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-03-01 至 2002-02-28

项目摘要

项目成果

CLAUDE F. MEARES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Monoclonal antibody technology allows the specificity of an antibody for its antigen to be used in targeting cancer cells. Bifunctional chelating agents are compounds with a strong metal chelating group at one end and a reactive functional group capable of binding to proteins at the other. When conjugated to monoclonal antibodies, these agents act as carriers of radiometals for tumor targeting. Over the past several years, we have created a number of new laboratory methods to prepare and characterize metal chelates for medical use. Mass spectrometry has much to offer in augmenting our methods to provide mass analysis of chelating agents and related compounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bispecific Antibody Engineering for AML RIT
Bispecific Antibody Engineering for AML RIT
Bispecific Antibody Engineering for AML RIT
Pretargeted Antibodies with Infinite Affinity
  • 批准号:
    6557062
  • 项目类别:
  • 资助金额:
    $24.07万
  • 财政年份:
    2003
  • 负责人:
    CLAUDE F. MEARES
  • 依托单位:
海外基金